Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.33 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.33 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11051243 | 0.73 | FFAR3 (0.43) | GRIK1GRIA4GRIK3GRIK5FFAR3 | |
| SCHEMBL18730440 | 0.73 | FFAR3 (0.36) | GRIK1GRIA4GRIK3GRIK5FFAR3 | |
| SCHEMBL1275702 | 0.71 | TSHR (0.32) | GRIK1GRIA4GRIK3GRIK5 | |
| SCHEMBL4475756 | 0.71 | TP53 (0.31) | GRIK1GRIA4GRIK3GRIK5 | |
| SCHEMBL1275715 | 0.71 | ALDH1A1 (0.40) | — | |
| SCHEMBL3516778 | 0.69 | GRIK1 (0.38) | GRIK1GRIA4GRIK3GRIK5FFAR3 | |
| SCHEMBL10193601 | 0.69 | GRIK1 (0.38) | GRIK1GRIA4GRIK3GRIK5FFAR3 | |
| SCHEMBL3516773 | 0.69 | GRIK1 (0.38) | GRIK1GRIA4GRIK3GRIK5FFAR3 | |
| SCHEMBL101165 | 0.68 | FFAR3 (0.53) | GRIK1GRIA4GRIK3GRIK5FFAR3 | |
| SCHEMBL21342603 | 0.68 | TSHR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153743-B2 | Controlled exotherm of cyanoacrylate formulations | CLOSURE MEDICAL CORPORATION (US) | 2012-04-10 | — | — | US | disclosed |
| EP-2413943-A1 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | Ethicon, Inc (US) | 2012-02-08 | — | — | EP | disclosed |
| EP-2307515-A2 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | Ethicon, Inc. (US) | 2011-04-13 | — | — | EP | disclosed |
| WO-2010114779-A1 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | ETHICON, INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| US-20100249698-A1 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | ETHICON, INC. | 2010-09-30 | — | — | US | disclosed |
| US-20100030258-A1 | Controlled Exotherm of Cyanoacrylate Formulations | ETHICON, INC. | 2010-02-04 | — | — | US | disclosed |
| WO-2010014641-A2 | CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS | CLOSURE MEDICAL CORPORATION (US) | 2010-02-04 | — | — | WO | disclosed |